Elicio Therapeutics (ELTX) Other Non Operating Income (2020 - 2026)
Elicio Therapeutics (ELTX) reported Other Non Operating Income of $13000.0 for Q1 2026, up 62.5% quarter-over-quarter from $8000.0 in Q4 2024.
Elicio Therapeutics (ELTX) Other Non Operating Income (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Other Non Operating Income for 6 years, with the latest figure at $13000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to $13000.0; the trailing twelve-month figure through Mar 2026 stood at $13000.0 (up 750.0% YoY), and the FY2024 full-year result was $151000.0, down 64.8% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $13000.0, up from $8000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $492000.0 in Q2 2023, with the low at -$945000.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged -$19454.5 across 4 years, with a median of $8000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 404.55% — and 2023, when it soared 543.24%.
- Elicio Therapeutics' Other Non Operating Income stood at -$945000.0 in 2022, then jumped by 96.51% to -$33000.0 in 2023, then surged by 124.24% to $8000.0 in 2024, then jumped by 62.5% to $13000.0 in 2026.
- The last three Other Non Operating Income figures came in at $13000.0 (Q1 2026), $8000.0 (Q4 2024), and -$1000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Sep 30, 2023 | -33,000.00 |
| Jun 30, 2023 | 492,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | -945,000.00 |
| Jun 30, 2022 | -111,000.00 |
| Mar 31, 2022 | 111,000.00 |
| Dec 31, 2021 | -7.19 Mn |
| Sep 30, 2021 | -204,000.00 |
| Jun 30, 2021 | -22,000.00 |
| Mar 31, 2021 | -53,000.00 |
| Dec 31, 2020 | 324,000.00 |
| Sep 30, 2020 | -3.34 Mn |
| Jun 30, 2020 | -1.92 Mn |
| Mar 31, 2020 | 245,000.00 |